Taltz 80 MG/ML autoinj (2-PK)ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9JX1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,200
Award facts
- Contract value 100% obligated
- $10,200.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $10.2K delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Taltz 80 mg/ml auto-injector two-packs. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a single-award vehicle valued at $999.999B through December 2026, which serves as the primary contracting mechanism for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical devices to federal agencies. The company's extensive portfolio of federal contract awards demonstrates its capability to efficiently fulfill government procurement requirements for pharmaceutical products across multiple therapeutic domains. This delivery order for Taltz, an immunosuppressant injection used to treat autoimmune conditions, represents a routine fulfillment under the company's comprehensive pharmaceutical supply agreement with DLA Troop Support, supporting the Defense Health Agency and other federal military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9JX1?
SPE2DR26F9JX1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F9JX1 worth?
The government has obligated $10,200 on SPE2DR26F9JX1.
Is contract SPE2DR26F9JX1 an order under another contract?
Yes. SPE2DR26F9JX1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JX1 competed?
The extent of competition for SPE2DR26F9JX1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award